DV Equities’s GSK GSK Stock Holding History

DV Equities’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.89M	Buy	+188,762	New	+$9.98M	1.42%	18
2025 Q4	$332K	Buy	+6,770	New	+$316K	0.06%	91

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

DV Equities's GSK Position: Q2 2026 in Review

DV Equities opened a new position in GSK (GSK) in Q2 2026: 188,762 shares worth $9.89M. The stake represents 1.42% of the portfolio and ranks #18 among its holdings. This is a return to the name: DV Equities previously reported a position in GSK as recently as Q4 2025.

DV Equities first reported a position in GSK in Q4 2025 and has held it in 2 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

DV Equities held 188,762 shares of GSK worth $9.89M as of Q2 2026.
GSK was a new DV Equities position in Q2 2026.
GSK made up 1.42% of DV Equities's portfolio in Q2 2026, its #18 holding.
DV Equities first reported a position in GSK in Q4 2025 and has held it in 2 quarters since.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on DV Equities's 13F filing for Q2 2026, filed 14 Aug 2026.